Growing adoption of biomarker-driven diagnostics is reshaping oncology care and accelerating market expansion. Cancer biomarkers are widely utilized across multiple stages of disease management, including diagnosis, prognosis, treatment monitoring, and recurrence detection. Their ability to provide accurate biological insights enables clinicians to make informed decisions and deliver more...